Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Bionomics Ltd (BNOEF)

Bionomics Ltd (BNOEF)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0034 -0.0026 (-43.33%) 09/19/23 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0034 unch (unch) -
Quote Overview for Tue, Sep 19th, 2023
Day Low
0.0034
Day High
0.0034
Open 0.0034
Previous Close 0.0060 0.0060
Volume 22,900 22,900
Avg Vol 170,130 170,130
Stochastic %K 43.36% 43.36%
Weighted Alpha -63.49 -63.49
5-Day Change -0.0046 (-57.50%) -0.0046 (-57.50%)
52-Week Range 0.0013 - 0.0550 0.0013 - 0.0550
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 4,452
  • Shares Outstanding, K 1,309,557
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta 1.86
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0027 +25.93%
on 08/30/23
Period Open: 0.0099
0.0099 -65.66%
on 08/22/23
-0.0065 (-65.66%)
since 08/18/23
3-Month
0.0013 +161.54%
on 08/14/23
Period Open: 0.0135
0.0260 -86.92%
on 06/23/23
-0.0101 (-74.81%)
since 06/16/23
52-Week
0.0013 +161.54%
on 08/14/23
Period Open: 0.0350
0.0550 -93.82%
on 11/16/22
-0.0316 (-90.29%)
since 09/16/22

Most Recent Stories

More News
Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial

Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment TORONTO, ON / ACCESSWIRE / February 11, 2021 / Novamind Inc. (CSE:NM) ("Novamind"), a leading mental health company...

BNO : 27.53 (-1.96%)
BNOEF : 0.0034 (-43.33%)
NM.CN : 0.295 (unch)
BNO.AX : 0.010 (unch)

Business Summary

Bionomics Limited is a biopharmaceutical company. It discovers and develops drug for the treatment of central nervous system disorders and cancer. The companys product pipeline includes BNC210, a novel and proprietary negative allosteric modulator, which is in Phase II clinical trials; BNC375, a small...

See More

Key Turning Points

3rd Resistance Point 0.0034
2nd Resistance Point 0.0034
1st Resistance Point 0.0034
Last Price 0.0034
1st Support Level 0.0034
2nd Support Level 0.0034
3rd Support Level 0.0034

See More

52-Week High 0.0550
Fibonacci 61.8% 0.0345
Fibonacci 50% 0.0281
Fibonacci 38.2% 0.0218
Last Price 0.0034
52-Week Low 0.0013

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective